The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy.

Bilich, Tatjana

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy. [electronic resource] - Blood 02 2019 - 550-565 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1528-0020

10.1182/blood-2018-07-866830 doi


Antigens, Neoplasm--immunology
CD4-Positive T-Lymphocytes--immunology
Epitopes, T-Lymphocyte--immunology
Fusion Proteins, bcr-abl--immunology
HLA Antigens--immunology
Humans
Immunotherapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--immunology
Ligands
T-Lymphocytes, Cytotoxic--immunology